Pehamberger H - Search Results

1

Lymph node sonography versus palpation for detecting recurrent disease in patients with malignant melanoma.

Binder M, Kittler H, Steiner A, Dorffner R, Wolff K, Pehamberger H. Binder M, et al. Among authors: pehamberger h. Eur J Cancer. 1997 Oct;33(11):1805-8. doi: 10.1016/s0959-8049(97)00177-9. Eur J Cancer. 1997. PMID: 9470837

2

Verrucous malignant melanoma.

Steiner A, Konrad K, Pehamberger H, Wolff K. Steiner A, et al. Among authors: pehamberger h. Arch Dermatol. 1988 Oct;124(10):1534-7. Arch Dermatol. 1988. PMID: 2971338

3

Increased nuclear volume in metastasizing "thick" melanomas.

Mossbacher U, Knollmayer S, Binder M, Steiner A, Wolff K, Pehamberger H. Mossbacher U, et al. Among authors: pehamberger h. J Invest Dermatol. 1996 Mar;106(3):437-40. doi: 10.1111/1523-1747.ep12343580. J Invest Dermatol. 1996. PMID: 8648173 Free article.

4

Limitations of high frequency ultrasound in determining the invasiveness of cutaneous malignant melanoma.

Partsch B, Binder M, Püspök-Schwarz M, Wolff K, Pehamberger H. Partsch B, et al. Among authors: pehamberger h. Melanoma Res. 1996 Oct;6(5):395-8. doi: 10.1097/00008390-199610000-00007. Melanoma Res. 1996. PMID: 8908600

5

Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine.

Seeber A, Binder M, Steiner A, Wolff K, Pehamberger H. Seeber A, et al. Among authors: pehamberger h. Eur J Cancer. 1998 Dec;34(13):2129-31. doi: 10.1016/s0959-8049(98)00316-5. Eur J Cancer. 1998. PMID: 10070323

6

A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999).

Kittler H, Binder M, Wolff K, Pehamberger H. Kittler H, et al. Among authors: pehamberger h. Wien Klin Wochenschr. 2001 Apr 30;113(9):321-7. Wien Klin Wochenschr. 2001. PMID: 11388077

7

Compliance with follow-up and prognosis among patients with thin melanomas.

Kittler H, Weitzdorfer R, Pehamberger H, Wolff K, Binder M. Kittler H, et al. Among authors: pehamberger h. Eur J Cancer. 2001 Aug;37(12):1504-9. doi: 10.1016/s0959-8049(01)00153-8. Eur J Cancer. 2001. PMID: 11506957

8

Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma.

Valencak J, Heere-Ress E, Kopp T, Schoppmann SF, Kittler H, Pehamberger H. Valencak J, et al. Among authors: pehamberger h. Eur J Cancer. 2004 Feb;40(3):358-64. doi: 10.1016/j.ejca.2003.09.009. Eur J Cancer. 2004. PMID: 14746853

9

Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.

Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E. Roka F, et al. Among authors: pehamberger h. Br J Cancer. 2005 Feb 28;92(4):662-7. doi: 10.1038/sj.bjc.6602391. Br J Cancer. 2005. PMID: 15700039 Free PMC article.

10

Fotemustine plus dacarbazine in advanced stage III malignant melanoma.

Binder M, Winkler A, Dorffner R, Glebowski E, Wolff K, Pehamberger H. Binder M, et al. Among authors: pehamberger h. Eur J Cancer. 1992;28A(11):1814-6. doi: 10.1016/0959-8049(92)90010-y. Eur J Cancer. 1992. PMID: 1389516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters